CCN3 (NOV) Is a Negative Regulator of CCN2 (CTGF) and a Novel Endogenous Inhibitor of the Fibrotic Pathway in an in Vitro Model of Renal Disease

por Riser, Bruce L., Najmabadi, Feridoon, Perbal, Bernard, Peterson, Darryl R., Rambow, Jo Ann, Riser, Melisa L., Sukowski, Ernest, Yeger, Herman, Riser, Sarah C.
Publicado 2009

CCN3/CCN2 regulation and the fibrosis of diabetic renal disease

por Riser, Bruce L., Najmabadi, Feridoon, Perbal, Bernard, Rambow, Jo Ann, Riser, Melisa L., Sukowski, Ernest, Yeger, Herman, Riser, Sarah C., Peterson, Darryl R.
Publicado 2010